Total Funding
37
54
Total FundingSeries B raised
Growth Score
0 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
72199
Viron Inc. is based in Boston, MA
- Gil Marmol: Founder & COO
Scott Waniger: Sr. Director Technical OperationsPast Role: Cell Culture Company, VP Bioprocessing
About the Company
Viron is a biopharmaceutical company that uses breakthrough discovery and novel technologies to identify and develop patent-pending high-value therapies for currently unarguable porosome protein and lipid targets in cancer, Alzheimer's, diabetes, neurological, digestive, and immune disorders. Breakthroughs in genomics and gene editing
technologies, stem cell biology, patient-derived organoids, cryo-electron microscopy, synthetic biology, small molecule screening, and image analysis using AI machine learning and high-throughput screening have transformed the drug discovery landscape.
